Abortion Rate Rises To 19.6 Per 1000 Women In The USA

In 1981 there were 29.3 abortions per 1000 women, compared to 19.4 in 2005 and 19.6 in 2008. The steady decline which lasted over two decades has stalled, and has started to rise slightly, according to a new report by the Guttmacher Institute. There were 1.21 million abortions in the United States in 2008…

Blogs Comment On Contraception, Home Birth, Other Topics

The following summarizes selected women’s health-related blog entries…

Workplace Exposure To Plasticizers And Pesticides May Lower Fertility

Workplace exposure to plasticizers and pesticides may lower a woman’s fertility and increase her chances of having a lower birthweight baby, suggests research published online in Occupational and Environmental Medicine. The researchers base their findings on 6,000 women during various stages of their pregnancy, with due dates between 2002 and 2006…

FDA Reviewers Uncertain of New Pancreatic Drug

WASHINGTON (MedPage Today) — An investigational pancreatic enzyme medication, liprotamase (Solpura) appears to be effective in treating pancreatic insufficiency — but FDA reviewers question whether the drug works as well as other products on the market.

Simplified Rx Refills May Boost Adherence (CME/CE)

(MedPage Today) — Patients who had multiple drug prescriptions with different refill schedules and from different prescribers tended not to take cardiovascular medications when they should, according to data from a large pharmacy benefit manager.

Healthcare Repeal Vote Delayed in Shooting Aftermath

WASHINGTON (MedPage Today) — The vote on the Republicans’ bill to repeal the Affordable Care Act will be postponed in the aftermath of the Arizona shooting that left six dead and 14 injured, including Rep. Gabrielle Giffords (D-Ariz.), who is hospitalized with a gunshot wound to the head.

LibiGel may be the first FDA approved product to treat HSDD in menopausal women

BioSante Pharmaceuticals, Inc., a pharmaceutical company developing products for the treatment of female sexual health, today announced results of a survey of over 100 Obstetrician/Gynecologists and Primary Care Physicians regarding the need for an FDA-approved drug to treat a form of Female Sexual Dysfunction (FSD) known as Hypoactive Sexual Desire Disorder (HSDD).

Enobia Pharma completes ENB-0040 Phase II study in juveniles with hypophosphatasia

Enobia Pharma, today announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia, a serious, rare metabolic bone disorder.

Celator, Cephalon extend cancer research agreement

Celator Pharmaceuticals today announced that it has agreed with Cephalon, Inc. to extend an existing research agreement into the next phase of development. The research agreement provides for the utilization of Celator’s proprietary technology in an ongoing drug development and life-cycle management program at Cephalon.

Advanced Targeting Systems awarded $3 million NCI grant to advance SP-SAP clinical program

Advanced Pain Remedies, a subsidiary of Cato BioVentures, announces that a three million dollar grant has been received, to advance its lead development candidate, SP-SAP. Advanced Targeting Systems, the company that pioneered the targeting of specific cell types to manipulate them for the treatment of diseases, has been awarded a $3 million grant from the [...]